Oncotarget is a weekly open access medical journal covering research on all aspects of oncology. It covers the latest developments in the field of oncology. It helps oncologists to learn about new technologies and drugs to treat cancer. This journal was established in 2010 releasing its publications weekly. It covers all the news that’s circulating in the medical world with special focus on oncology. Oncotarget is a peer to peer review journal and oncologists from all over the world can send their reports and researches to be published in this newsletter. This newsletter began with an aim to increase awareness among the public regarding cancer and Mikhail’s effective treatments and to allow oncologists to share the new discoveries and research in this field with the world.
This newsletter is very diverse. It covers almost all the areas of oncological research. It highlights easier and affordable treatment methods and the new drugs that are more beneficial to patients with lesser side effects than the previous ones. This increases the interest of readers in this newsletter. It also tries to cover opinions and reviews regarding new methodologies and technologies for treating cancer. This not only helps doctors to acquire them but also patients to become aware of them.One of the major benefits of this newsletter which it provides its readers is that it is an open access publication.
Anyone can read it free of cost. This was founded by Mikhail Blagosklonny and Andrei Gudkov, the two highly prominent figures in the field of medicine specifically oncology. Their primary purpose for publishing this newsletter was to spread knowledge and awareness among common people as well as doctors regarding the field of oncology. This alos helps in appreciating the efforts of researchers who work hard to bring improvements in the treatment of cancer. Both Blagosklonny and Gudkov review each and every article that wants to get published in it. After their approval, the articles get published. This is done to ensure that right information is delivered to the readers. So that people can easily trust what they read in these articles.